Sun Pharma arm- SPARC application for cancer drug Taclantis rejected by USFDA Medical Dialogues Bureau12 Feb 2020 1:10 PM IST"The company has received a Complete Response Letter (CRL) from the United States Food & Drug Administration (USFDA) for the new drug application...
Overcharging on Anti-diabetic, Cardiac Care Drugs: Rs 245.96 crore recovered from Pharma Firms, Minister informs Parliament Farhat Nasim6 Feb 2020 4:43 PM ISTNPPA has detected and issued about 162 demand notices against the pharmaceutical companies for overcharging consumers on the sale of Anti-diabetic and...
German drug assessment body not convinced by Bayer's cancer drug Vitrakvi Medical Dialogues Bureau19 Jan 2020 9:30 AM ISTFrankfurt: Germany's drug assessment body said that data provided by Bayer on its precision cancer drug Vitrakvi did not provide clear enough evidence...
Shilpa Medicare gets USFDA approval for generic equivalent of cancer drug TARCEVA Farhat Nasim8 Nov 2019 10:00 AM ISTErlotinib Tablets, 25 mg, 100 mg, and 150 mg is a generic equivalent of reference listed drug (RLD) TARCEVA used in the treatment of patients with...
Natco Pharma settles patent litigation with Onyx Therapeutics over anti cancer drug- Kyprolis Medical Dialogues Bureau1 Jun 2019 2:39 PM ISTNew Delhi: Natco Pharma Thursday said it has settled patent litigation with Onyx Therapeutics Inc in the US over a generic version of Kyprolis, an...
Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis Medical Dialogues Bureau30 May 2019 5:12 PM ISTKyprolis is the trade name for the generic drug Carfilzomib. The anti-cancer drug is a targeted therapy and is classified as a Proteasome Inhibitor....
Biocon, Mylan gets Canadian nod for biosimilar of cancer drug Herceptin Farhat Nasim23 May 2019 11:59 AM ISTOgivri is the first trastuzumab biosimilar approved in Canada and the second biosimilar from Biocon and Mylan's joint portfolio approved in the...
Shilpa Medicare gets USFDA nod for Irinotecan injection to treat cancer Farhat Nasim17 May 2019 1:45 PM ISTIrinotecan injection is used in the treatment of patients with metastatic carcinoma of the colon or rectum, the company added. NEW DELHI: Shilpa...
Intas Pharma launches Cancer Drug Eleftha for Rs 19,995; 65 percent lower than market rate Meghna A Singhania11 April 2019 10:50 AM ISTMumbai: In a move that will provide relief to cancer patients, drugmaker Intas Pharmaceuticals has recently announced the launch of Trastuzumab...
Sun Pharma launches cancer drug INFUGEM in US market Farhat Nasim9 April 2019 10:05 AM ISTSun Pharma said INFUGEM uses its proprietary technology which allows cytotoxic oncology products to be premixed in a sterile environment and supplied...
Pfizer gets EU nod to VIZIMPRO for treating lung cancer Farhat Nasim6 April 2019 9:40 AM ISTNew Delhi: Pfizer Inc. recently announced that the European Commission has approved VIZIMPRO (dacomitinib), a tyrosine kinase inhibitor (TKI), as...
Emcure launches generic Eribulin at 40 percent lower price in India Farhat Nasim4 April 2019 9:30 AM ISTEmcure Pharmaceuticals will manufacture Eribulin at its plant at Hinjewadi in Pune and market it at a cost which will be approximately 40 per cent...
